Concepedia

Author

Gareth Gerrard

Imperial College LondonORCID

Also Known As

G E Gerrard, G Gerrard, G. Gerrard, G.E Gerrard, G.E. Gerrard, Gareth Gerrard, Georgina Gerrard, Gerrard, G

141

Publications

3.5K

Citations

27

H-Index

70

Concepts

All Affiliations

Imperial College LondonHammersmith HospitalImperial College Healthcare NHS TrustUniversity College LondonSt James's University Hospital
GG

About

Gareth Gerrard is an author at Imperial College London specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

18

634

2

Health Sciences

7

7

246

3

Engineering

2

2

52

4

Nursing

1

1

10

5

Public Health

1

1

10

Gareth Gerrard

×

43

Publications

3.1K

Citations

24

H-Index

YearCitations

Assessment of <i>BCR-ABL1</i> Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors

David Marín, Amr R. Ibrahim, Claire Lucas,

Journal of Clinical Oncology

2011

474

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

Adele K. Fielding, Jacob M. Rowe, Georgina Buck,

Blood

2013

365

Regulation of myeloid leukaemia by the cell-fate determinant Musashi

Takahiro Ito, Hyog Young Kwon, Bryan Zimdahl,

Nature

2010

364

Poor adherence is the main reason for loss of CCyR and imatinib failure for chronic myeloid leukemia patients on long-term therapy

Amr R. Ibrahim, Lina Eliasson, Jane F. Apperley,

Blood

2011

314

Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

Bella Patel, Lena Rai, Georgina Buck,

British Journal of Haematology

2009

151

Guidelines for the measurement of <i>BCR‐ABL1</i> transcripts in chronic myeloid leukaemia

Letizia Foroni, Gill Wilson, Gareth Gerrard,

British Journal of Haematology

2011

104

Combining BCR-ABL1 transcript levels at 3 and 6 months in chronic myeloid leukemia: implications for early intervention strategies

Pratap Neelakantan, Gareth Gerrard, Claire Lucas,

Blood

2013

93

Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.

Gareth Gerrard, Elspeth Payne, Robert J. Baker,

PubMed

2004

93

Molecular diagnosis of the myeloproliferative neoplasms: <scp>UK</scp> guidelines for the detection of <i><scp>JAK</scp>2 </i><scp>V</scp>617<scp>F</scp> and other relevant mutations

Anthony J. Bench, Helen White, Letizia Foroni,

British Journal of Haematology

2012

92

A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR

Helen White, Liesbet Deprez, Philippe Corbisier,

Leukemia

2014

81

Page 1